IGC Pharma, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
IGC NYSE American 2830 igcpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for IGC Pharma, Inc.

New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX) - Apr 11th, 2026 7:35 am
Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.25, Citing Clinical Progress and Upcoming Catalysts - Apr 8th, 2026 10:45 am
IGC Pharma Adds Tandem Clinical Research to the CALMA Trial for Agitation in Alzheimer's Disease - Apr 7th, 2026 6:00 am
IGC Pharma Launches Strategic National Media Partnership with New to The Street to Expand Investor Awareness - Mar 30th, 2026 6:00 am
New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX) - Mar 28th, 2026 9:00 am
IGC Pharma, New to The Street launch 12-part national media partnership - Mar 26th, 2026 6:20 am
New to The Street and IGC Pharma (NYSE American:IGC) Launch Strategic 12-Part National Media Partnership to Accelerate Investor Awareness and Market Positioning - Mar 25th, 2026 6:00 am
electroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates - Mar 19th, 2026 3:45 pm
IGC Pharma Reports Financial Results and Clinical Progress for the Period Ended December 31, 2025 - Mar 19th, 2026 7:00 am
4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings and Revenues Beat Estimates - Mar 18th, 2026 3:25 pm
IGC Pharma to Showcase AI Platform with Alzheimer's Disease Data Initiative at ADPD 2026 - Mar 18th, 2026 7:00 am
Merck KGaA (MKKGY) Lags Q4 Earnings Estimates - Mar 5th, 2026 5:05 am
IGC Pharma Files Utility Patent Applications Covering AI-Based Data Harmonization Architecture Supporting Alzheimer's Research - Feb 26th, 2026 6:30 am
IGC Pharma expands Phase 2 CALMA trial with new clinical site - Feb 24th, 2026 6:49 am
IGC Pharma Notes Updated Research Coverage from Ascendiant Capital Markets - Feb 24th, 2026 6:30 am
IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial - Feb 23rd, 2026 6:30 am
IGC Pharma Secures North American Composition Protection for IGC-AD1 as Phase 2 CALMA Enrollment Advances - Feb 17th, 2026 6:30 am
IGC Pharma to Participate in Fireside Chat With Ascendiant Capital Markets - Feb 12th, 2026 6:30 am
IGC Pharma Announces Equity Research Update by Alliance Global Partners - Feb 10th, 2026 6:30 am
IGC Pharma Expands Phase 2 CALMA Trial into Colombia's Premier Alzheimer's Research Center - Feb 9th, 2026 6:30 am